title: Cerebral aspergillosis in systemic lupus erythematosus.
authors.affiliation: Department of Medicine B, University of Münster, Germany. gaubitz@uni-muenster.de
authors.forename: M
authors.initials: M
authors.lastname: Gaubitz
authors.forename: D
authors.initials: D
authors.lastname: Moskopp
authors.forename: W
authors.initials: W
authors.lastname: Fegeler
authors.forename: E
authors.initials: E
authors.lastname: Hilker
authors.forename: W
authors.initials: W
authors.lastname: Domschke
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001921:Brain / Q000382:microbiology / Q000473:pathology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017964:Itraconazole / Q000627:therapeutic use; D008081:Liposomes; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D020953:Neuroaspergillosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D014057:Tomography, X-Ray Computed
chemical_list: D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D008081:Liposomes; D017964:Itraconazole; D000666:Amphotericin B; D003520:Cyclophosphamide